US Patent Issued to Icahn School of Medicine at Mount Sinai on Jan. 3 for "Compositions and methods for treating CDK4/6-mediated cancer" (New York, New Jersey Inventors)

Press/Media

Period21 Jan 2023

Media coverage

1

Media coverage